Stock Watch: Exploring Biotech’s Route Through Bubble And Wilderness
A Biotech Recovery May Be Some Way Off
Biotech has always been a volatile sector, and it is important for investors to recognize the phases its stocks go through. In particular, the journey through the post-bubble wilderness can be a protracted affair.
